NEW LIGANDS FOR L-TYPE CA-2+ CHANNELS

被引:61
作者
RAMPE, D [1 ]
TRIGGLE, DJ [1 ]
机构
[1] SUNY BUFFALO,SCH PHARMACOL,BUFFALO,NY 14260
关键词
(+)-PN 200-110; isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-methoxycarbonylpyridine-3-carboxylate; N-ω-aminohexyl-5-chloronaphthalenesulfonamide; W-7;
D O I
10.1016/0165-6147(90)90196-F
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although the clinically important categories of drug represented by verapamil, nifedipine and diltiazem are defined as acting at three major and discrete sites on the L class of voltage-dependent Ca2+ channel, it is likely that some new classes of drug modulate channel activity by acting at additional sites. David Rampe and David Triggle describe the actions of some of these new drugs, which may both offer improved therapeutic and side-effect profiles over existing agents and provide information to define further the structure and function of this channel class. These drugs may mimick the actions of endogenous ligand(s) and such ligands could provide new directions for Ca2+ channel drug structures. © 1990.
引用
收藏
页码:112 / 115
页数:4
相关论文
共 39 条
[1]   (+)-NIGULDIPINE BINDS WITH VERY HIGH-AFFINITY TO CA-2+ CHANNELS AND TO A SUBTYPE OF ALPHA-1-ADRENOCEPTORS [J].
BOER, R ;
GRASSEGGER, A ;
SCHUDT, C ;
GLOSSMANN, H .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (02) :131-145
[2]  
BROWN AM, 1987, CIRC RES, V61, P6
[3]   MODULATION OF CALCIUM CHANNELS IN CARDIAC AND NEURONAL CELLS BY AN ENDOGENOUS PEPTIDE [J].
CALLEWAERT, G ;
HANBAUER, I ;
MORAD, M .
SCIENCE, 1989, 243 (4891) :663-666
[4]   2-ETHYNYLBENZENEALKANAMINES - A NEW CLASS OF CALCIUM ENTRY BLOCKERS [J].
CARSON, JR ;
ALMOND, HR ;
BRANNAN, MD ;
CARMOSIN, RJ ;
FLAIM, SF ;
GILL, A ;
GLEASON, MM ;
KEELY, SL ;
LUDOVICI, DW ;
PITIS, PM ;
REBARCHAK, MC ;
VILLANI, FJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (03) :630-636
[5]   CHARACTERIZATION OF THE OMEGA-CONOTOXIN TARGET - EVIDENCE FOR TISSUE-SPECIFIC HETEROGENEITY IN CALCIUM-CHANNEL TYPES [J].
CRUZ, LJ ;
JOHNSON, DS ;
OLIVERA, BM .
BIOCHEMISTRY, 1987, 26 (03) :820-824
[6]  
EBERSOLE BJ, 1988, J PHARMACOL EXP THER, V244, P971
[7]   PHARMACOLOGIC EFFECTS OF WY-27569 - A COMBINED CALCIUM-CHANNEL BLOCKER AND THROMBOXANE SYNTHETASE INHIBITOR [J].
ENNIS, C ;
GRANGER, SE ;
MIDDLEFELL, VC ;
PHILPOT, ME ;
SHEPPERSON, NB .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 (04) :511-519
[8]  
FERRANTE J, IN PRESS BIOCH PHARM
[9]   EFFECTS OF THE NOVEL CALCIUM-CHANNEL BLOCKER, MCN-5691, ON CARDIOCIRCULATORY DYNAMICS AND CARDIAC-OUTPUT DISTRIBUTION IN CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RAT [J].
FLAIM, SF ;
STRANIERI, MT ;
GILL, A ;
CARSON, JR ;
BRANNAN, MD .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (04) :489-500
[10]   TOXINS THAT AFFECT VOLTAGE-DEPENDENT CALCIUM CHANNELS [J].
HAMILTON, SL ;
PEREZ, M .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (20) :3325-3329